Free tool
Biotech Stock Screener
Filter clinical-stage biotech companies by pipeline phase, therapeutic area, and market cap.
35 of 35 companies
AbbVie
AbbVie is a commercial-stage biotech company that investors generally judge on execution, not just science.
View profile
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals is a commercial-stage biotech company that investors generally judge on execution, not just science.
View profile
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a commercial-stage biotech company that investors generally judge on execution, not just science.
View profile
Amgen
Amgen is a commercial-stage biotech company that investors generally judge on execution, not just science.
View profile
argenx SE
argenx developed Vyvgart which lowers harmful antibody levels by blocking FcRn receptor.
View profile
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a clinical-stage biotech company that investors generally judge on execution, not just science.
View profile
Beam Therapeutics
Beam Therapeutics is a clinical-stage biotech company that investors generally judge on execution, not just science.
View profile
Biogen
Biogen is a commercial-stage biotech company that investors generally judge on execution, not just science.
View profile
bluebird bio
bluebird bio is a clinical-stage biotech company that investors generally judge on execution, not just science.
View profile
BioMarin Pharmaceutical
BioMarin is a well-established rare disease company that has successfully transitioned to commercial profitability.
View profile
CRISPR Therapeutics
CRISPR Therapeutics is, quite literally, the company that brought gene editing from science fiction to reality.
View profile
Denali Therapeutics
Denali Therapeutics is a clinical-stage biotech company that investors generally judge on execution, not just science.
View profile
Dyne Therapeutics
Dyne Therapeutics is a clinical-stage biotech company that investors generally judge on execution, not just science.
View profile
Erasca
Erasca is a clinical-stage biotech company that investors generally judge on execution, not just science.
View profile
Amicus Therapeutics
Amicus Therapeutics is a commercial-stage biotech company that investors generally judge on execution, not just science.
View profile
Gilead Sciences
Gilead Sciences is a commercial-stage biotech company that investors generally judge on execution, not just science.
View profile
Halozyme Therapeutics
Halozyme Therapeutics is a commercial-stage biotech company that investors generally judge on execution, not just science.
View profile
Immunovant
Immunovant is a clinical-stage biotech company that investors generally judge on execution, not just science.
View profile
Incyte
Incyte is a commercial-stage biotech company that investors generally judge on execution, not just science.
View profile
Ionis Pharmaceuticals
Ionis Pharmaceuticals is a clinical-stage biotech company that investors generally judge on execution, not just science.
View profile
Karuna Therapeutics
Karuna Therapeutics is a clinical-stage biotech company that investors generally judge on execution, not just science.
View profile
MindMed
MindMed is developing what could be the most radical new approach to treating anxiety in decades: a single supervised dose of a psychedelic medicine that rel…
View profile
Moderna
Moderna is the company that made one of the two big COVID vaccines.
View profile
Mirati Therapeutics
Mirati Therapeutics is a clinical-stage biotech company that investors generally judge on execution, not just science.
View profile
Intellia Therapeutics
Intellia Therapeutics is trying to do something no company has ever done: prove that you can safely edit a person's genes while they're still inside their body.
View profile
Vaxcyte
Vaxcyte is a clinical-stage biotech company that investors generally judge on execution, not just science.
View profile
Prothena
Prothena is a clinical-stage biotech company that investors generally judge on execution, not just science.
View profile
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical is a clinical-stage biotech company that investors generally judge on execution, not just science.
View profile
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a commercial-stage biotech company that investors generally judge on execution, not just science.
View profile
Royalty Pharma
Royalty Pharma is a commercial-stage biotech company that investors generally judge on execution, not just science.
View profile
Recursion Pharmaceuticals
Recursion Pharmaceuticals is a clinical-stage biotech company that investors generally judge on execution, not just science.
View profile
Cassava Sciences
Cassava Sciences is a clinical-stage biotech company that investors generally judge on execution, not just science.
View profile
Sarepta Therapeutics
Sarepta Therapeutics is a commercial-stage biotech company that investors generally judge on execution, not just science.
View profile
Viking Therapeutics
Viking Therapeutics is one of the most talked-about small biotech companies in the market right now, and the reason is simple: they may have cracked the code…
View profile
Vertex Pharmaceuticals
Vertex Pharmaceuticals is a commercial-stage biotech company that investors generally judge on execution, not just science.
View profile
Coming soon
Real-time filtering by PDUFA date proximity and upcoming catalysts is in development. Filtering by pipeline phase, therapeutic area, and market cap is available now above.
Want alerts for new catalysts?
Get notified when companies on your watchlist have upcoming FDA events.
Subscribe free